23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Caris Life Sciences, Inc. › 2025-2026

Caris Life Sciences, Inc. 2025-2026 Proxy Voting Records

At Caris Life Sciences, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 65 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 2,711 separate fund positions. On the most widely held item on that ballot — TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED… — Caris Life Sciences, Inc.'s filing reports the proposal as approved, with 99.9% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Caris Life Sciences, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Caris Life Sciences, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 11Ballot items
  • 65Asset managers
  • 2,711Fund votes
  • June 4, 2026Meeting date

Results at a glance

Meeting of June 4, 2026: 11 items on Caris Life Sciences, Inc.’s Form 8-K, filed June 5, 2026: 10 elected · 1 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore Caris Life Sciences, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Caris Life Sciences, Inc.

These tallies are Caris Life Sciences, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Caris Life Sciences, Inc. — official shareholder meeting results, meeting held June 4, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: David Dean Halbert 216,983,424---- 45,644,07011,087,026 83%Elected—
Elect Director: Brian J. Brille 216,953,607---- 45,673,88711,087,026 83%Elected—
Elect Director: Peter M. Castleman 200,435,909---- 62,191,58511,087,026 76%Elected—
Elect Director: David Fredrickson 228,579,061---- 34,048,43311,087,026 87%Elected—
Elect Director: Joseph E. Gilliam 215,798,279---- 46,829,21511,087,026 82%Elected—
Elect Director: Jon S. Halbert 215,600,787---- 47,026,70711,087,026 82%Elected—
Elect Director: Laura I. Johansen 227,201,421---- 35,426,07311,087,026 87%Elected—
Elect Director: Dr. Lloyd B. Minor 228,662,425---- 33,965,06911,087,026 87%Elected—
Elect Director: Danny Phillips 214,817,153---- 47,810,34111,087,026 82%Elected—
Elect Director: Dr. Jeffrey Vacirca 228,673,484---- 33,954,01011,087,026 87%Elected—
2. Ratification of Appointment of Independent Registered Public Accounting Firm The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 273,517,32460,882136,314 ---- 99.9%Approved—

Source: Caris Life Sciences, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.

How asset managers voted at the Caris Life Sciences, Inc. 2025-2026 meeting

Each item below shows how the 65 asset managers that disclosed a Caris Life Sciences, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Dr. Jeffrey Vacirca

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 228,673,484WITHHELD: 33,954,010
Details: description as filed, official tally, votes by 64 asset managers

Description as filed by funds: Election of Directors: Jeffrey Vacirca, M.D.

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Dr. Jeffrey Vacirca”): 228,673,484 for, 33,954,010 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 17,646,588 for, 29,616,450 withheld, 30,139 abstained.

FORWITHHOLD
FOR: 17,646,588ABSTAIN: 30,139WITHHOLD: 29,616,450
Largest asset managers voting on “Election of Directors: Jeffrey Vacirca, M.D.” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity740,3640 027,375,491Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,510,8950 92,222,482Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal196,7170 00For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica91,8590 00For
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).

2. Elect Director: Brian J. Brille

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD
FOR: 216,953,607WITHHELD: 45,673,887
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Brian J. Brille

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Brian J. Brille”): 216,953,607 for, 45,673,887 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 16,759,107 for, 30,492,535 withheld, 37,249 abstained.

FORWITHHOLD
FOR: 16,759,107ABSTAIN: 37,249WITHHOLD: 30,492,535
Largest asset managers voting on “Election of Directors: Brian J. Brille” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity49,2390 028,066,616Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,505,5880 122,227,786Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal195,4650 01,252For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica00 091,859Withhold
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

3. Elect Director: Danny Phillips

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD
FOR: 214,817,153WITHHELD: 47,810,341
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Danny Phillips

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Danny Phillips”): 214,817,153 for, 47,810,341 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 16,504,664 for, 30,749,711 withheld, 34,516 abstained.

FORWITHHOLD
FOR: 16,504,664ABSTAIN: 34,516WITHHOLD: 30,749,711
Largest asset managers voting on “Election of Directors: Danny Phillips” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity734,1640 027,381,691Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,505,5880 122,227,786Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle00 0484,361Withhold
MFS00 0263,544Withhold
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal195,4650 01,252For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group00 0141,367Withhold
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable46,8960 054,505Mixed
AIG/SunAmerica00 091,859Withhold
State Street68,3450 02,390For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

4. Elect Director: David Dean Halbert

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD
FOR: 216,983,424WITHHELD: 45,644,070
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: David Dean Halbert

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: David Dean Halbert”): 216,983,424 for, 45,644,070 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 16,740,509 for, 30,511,134 withheld, 37,248 abstained.

FORWITHHOLD
FOR: 16,740,509ABSTAIN: 37,248WITHHOLD: 30,511,134
Largest asset managers voting on “Election of Directors: David Dean Halbert” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity49,2390 028,066,616Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,505,5890 112,227,786Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal195,4650 01,252For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica00 091,859Withhold
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

5. Elect Director: David Fredrickson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 228,579,061WITHHELD: 34,048,433
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: David Frederickson

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: David Fredrickson”): 228,579,061 for, 34,048,433 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 17,642,302 for, 29,616,450 withheld, 30,139 abstained.

FORWITHHOLD
FOR: 17,642,302ABSTAIN: 30,139WITHHOLD: 29,616,450
Largest asset managers voting on “Election of Directors: David Frederickson” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity740,3640 027,375,491Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,510,8950 92,222,482Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal196,7170 00For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica91,8590 00For
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

6. Elect Director: Jon S. Halbert

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD
FOR: 215,600,787WITHHELD: 47,026,707
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Jon S. Halbert

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Jon S. Halbert”): 215,600,787 for, 47,026,707 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 16,495,786 for, 30,755,856 withheld, 37,249 abstained.

FORWITHHOLD
FOR: 16,495,786ABSTAIN: 37,249WITHHOLD: 30,755,856
Largest asset managers voting on “Election of Directors: Jon S. Halbert” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity49,2390 028,066,616Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,505,5880 122,227,786Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS00 0263,544Withhold
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal195,4650 01,252For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica00 091,859Withhold
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

7. Elect Director: Joseph E. Gilliam

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD
FOR: 215,798,279WITHHELD: 46,829,215
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Joseph E. Gilliam

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Joseph E. Gilliam”): 215,798,279 for, 46,829,215 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 16,698,860 for, 30,555,515 withheld, 34,516 abstained.

FORWITHHOLD
FOR: 16,698,860ABSTAIN: 34,516WITHHOLD: 30,555,515
Largest asset managers voting on “Election of Directors: Joseph E. Gilliam” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity734,1640 027,381,691Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,505,5880 122,227,786Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle00 0484,361Withhold
MFS00 0263,544Withhold
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal195,4650 01,252For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica00 091,859Withhold
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

8. Elect Director: Laura I. Johansen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 227,201,421WITHHELD: 35,426,073
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Laura I. Johansen

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Laura I. Johansen”): 227,201,421 for, 35,426,073 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 17,592,369 for, 29,666,383 withheld, 30,139 abstained.

FORWITHHOLD
FOR: 17,592,369ABSTAIN: 30,139WITHHOLD: 29,666,383
Largest asset managers voting on “Election of Directors: Laura I. Johansen” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity740,3640 027,375,491Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,510,8950 92,222,482Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal196,7170 00For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable46,8960 054,505Mixed
AIG/SunAmerica91,8590 00For
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

9. Elect Director: Dr. Lloyd B. Minor

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 228,662,425WITHHELD: 33,965,069
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Lloyd B. Minor, M.D.

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Dr. Lloyd B. Minor”): 228,662,425 for, 33,965,069 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 17,642,302 for, 29,616,450 withheld, 30,139 abstained.

FORWITHHOLD
FOR: 17,642,302ABSTAIN: 30,139WITHHOLD: 29,616,450
Largest asset managers voting on “Election of Directors: Lloyd B. Minor, M.D.” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity740,3640 027,375,491Withhold
T. Rowe Price5,773,7720 00For
Vanguard1,510,8950 92,222,482Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal196,7170 00For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable96,2900 05,111Mixed
AIG/SunAmerica91,8590 00For
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

10. Elect Director: Peter M. Castleman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD
FOR: 200,435,909WITHHELD: 62,191,585
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: Election of Directors: Peter M. Castleman

Caris Life Sciences, Inc.’s own tally for this item (“Elect Director: Peter M. Castleman”): 200,435,909 for, 62,191,585 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The shareholder voting results by proposal are set forth in the tables below: Proposal No. 1: Election of Directors Each of the following director nominees was elected to serve for a term expiring at the 2027 Annual Meeting by the votes set forth in the table below.”
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 11,467,454 for, 34,428,906 withheld, 1,392,531 abstained.

FORWITHHOLD
FOR: 11,467,454ABSTAIN: 1,392,531WITHHOLD: 34,428,906
Largest asset managers voting on “Election of Directors: Peter M. Castleman” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity734,1640 027,381,691Withhold
T. Rowe Price2,700,5710 03,073,201Mixed
Vanguard1,503,8850 152,229,486Mixed
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock290,4860 815,4970Mixed
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National79,3230 476,3740Mixed
Columbia Threadneedle00 0484,361Withhold
MFS00 0263,544Withhold
OPTIMUM FUND TRUST00 0242,135Withhold
Federated Hermes203,7830 00For
Principal00 0196,717Withhold
Nationwide960 0153,007Withhold
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable42,1360 059,265Mixed
AIG/SunAmerica00 091,859Withhold
State Street68,3450 02,390For
Bridge Builder Trust45,5550 11,8050Mixed
MASTER INVESTMENT PORTFOLIO30,6790 22,7850Mixed
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

11. Ratification of Appointment of Independent Registered Public Accounting Firm The selection of Deloitte & Touche LLP as…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 273,517,324AGAINST: 60,882
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Caris Life Sciences, Inc.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31”): 273,517,324 for, 60,882 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the shareholders by the votes set forth in …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 47,295,203 for, 6,927 abstained.

FOR
FOR: 47,295,203ABSTAIN: 6,927
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING F” at Caris Life Sciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity28,115,8550 00For
T. Rowe Price5,773,7720 00For
Vanguard3,733,3850 00For
JPMorgan2,252,4910 00For
Legg Mason1,272,6160 00For
BlackRock1,105,9830 00For
Invesco986,8340 00For
Advisors' Inner Circle Fund II556,0000 00For
Jackson National555,6970 00For
Columbia Threadneedle484,3610 00For
MFS263,5440 00For
OPTIMUM FUND TRUST242,1350 00For
Federated Hermes203,7830 00For
Principal196,7170 00For
Nationwide153,1030 00For
Northwestern Mutual141,7120 00For
Capital Group141,3670 00For
Eaton Vance135,8070 00For
Virtus131,5500 00For
Equitable101,4010 00For
AIG/SunAmerica91,8590 00For
State Street70,7350 00For
Bridge Builder Trust57,3600 00For
MASTER INVESTMENT PORTFOLIO53,4640 00For
Advisor Managed Portfolios43,8000 00For

Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).

Largest Caris Life Sciences, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 282,680,695 shares outstanding at the time of that meeting.

Fund voting reports: top Caris Life Sciences, Inc. shareholders by shares voted on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 9.95%
2T. Rowe Price 2.04%
3Vanguard 1.32%
4JPMorgan 0.80%
5Legg Mason 0.45%
6BlackRock 0.39%
7Invesco 0.35%
8Advisors' Inner Circle Fund II 0.20%
9Jackson National 0.20%
10Columbia Threadneedle 0.17%
Institutional-manager reports: top Caris Life Sciences, Inc. shareholders by shares voted on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED…”, 2025-2026
#Asset manager % of shares outstanding
1Keel Point, LLC <0.01%

Reported Caris Life Sciences, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Caris Life Sciences, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
David Dean Halbert 44.22% DEF14A
FMR (Fidelity) 10.89% 13F
FMR LLC 10.84% 13G
Entities affiliated with Sixth Street 6.86% DEF14A
Entities affiliated with J.H. Whitney 6.46% DEF14A
J H Whitney VI L P 3.98% 13G
Peter M. Castleman 3.69% DEF14A
Alan Waxman 2.59% 13G
BlackRock 1.72% 13F
T. Rowe Price 1.55% 13F

Percentages above are of 282,680,695 shares outstanding, as reported by Caris Life Sciences, Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Caris Life Sciences, Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Caris Life Sciences, Inc. proxy season coverage: 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “Caris Life Sciences (CAI) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/caris-life-sciences-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.